p-Smad3 is a key molecule in the TGF-β signaling pathway [15], and previous studies showed that TGF-β in the tumor microenvironment downregulates HLA class I expression on tumor cells of malignant melanoma [13,14]. The gene discussed is SMAD3; the disease is neoplasm.